During Breast Cancer Awareness Month, The Aesthetic Foundation is highlighting the various ways that our members and donors are making an impact on patients and the specialty.
This is my last newsletter as President of The Aesthetic Foundation, and it has been a busy and productive year. Our core mission is to support research that is relevant to practicing plastic surgeons and improve the safety and effectiveness of the procedures that we offer to our patients.
In this month’s update, Dr. Tracy Pfeifer highlights all things The Aesthetic MEET, reflecting on her time as president and how she got involved in The Aesthetic Society, and check out the blooper reel at the end!
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and Sodium-glucose cotransporter 2 (SGLT-2) inhibitors are widely used for Type 2 diabetes and weight management but may adversely affect skin quality, resulting in dermal thinning, decreased elasticity, and accelerated aging—a phenomenon referred to as “GLP-1 Face.”